Lenzing Ag will phase out fiber production at two European sites — one in Austria and one in the United Kingdom — and reorient capacity toward nonwovens, according to trade publication EUWID Pulp and Paper.

The closures, disclosed in EUWID's coverage of the Austrian cellulosic fiber group's strategic update, remove two filament yarn production nodes from Lenzing's European footprint. The group will channel investment into its nonwovens business — the segment serving hygiene, wipes, and medical textile converters with engineered fabrics bonded directly from fibers rather than woven or knitted from yarn.

What nonwovens capacity means in this portfolio shift

Nonwovens represent Lenzing's higher-margin growth lane, with established demand from flushable wipes, femcare, medical disposables, and filtration converters. By withdrawing from filament yarn for apparel and home textiles at two locations, Lenzing concedes filament share to competitors. It concentrates capital instead on the substrate category where cellulosic biodegradability and skin-contact credentials carry pricing power with private-label and brand-owner converters.

For sourcing teams, the immediate question is continuity of filament supply to existing yarn customers.

What does the change mean for apparel and home-textile buyers?

Buyers currently drawing filament yarn from the affected Austrian and UK lines must qualify alternative European or Asian cellulosic yarn suppliers within the transition window. EUWID's account does not specify which sites are exiting or how many tonnes of annual filament capacity the closures will remove. That gap keeps spinners, weavers, and knitters in a holding pattern until Lenzing confirms timelines, transfer volumes, and last-order dates.

The shift also tightens the European cellulosic yarn supply base. With fewer European filament lines, qualifying a second-source supplier outside the bloc becomes a higher-priority continuity step for brands carrying cellulose-fiber origin claims tied to European feedstock.

Why is Lenzing doubling down on nonwovens?

Nonwoven applications — wipes, hygiene layers, surgical fabrics, filtration media — have posted volume growth that textile filament has not matched since the post-pandemic unwind. Capital allocation follows the demand: cellulosic nonwovens compete against polypropylene and polyester substrates where biodegradability, flushability, and dermatological claims carry commercial weight with retailer own-label buyers and healthcare procurement.

The sourcing decision this forces

Sourcing managers with filament yarn on purchase order into 2026 should now request from their Lenzing account team:

• A confirmed exit timeline and last-acceptance date for orders on the two closing lines
• Equivalent-tonnage allocation or transition supply at comparable specifications
• Re-verification of any sustainability, FSC, or Canopy-style origin claim currently tied to the phasing-out sites
• Confirmation of which Lenzing sites will carry the firm's European filament capacity forward

Until Lenzing publishes site-level detail and closure dates, brand owners carrying European-cellulose claims should treat any sustainability statement touching the closing lines as a compliance item requiring re-audit once capacity transitions complete.